(Q44817223)

English

Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease

scientific article published in May 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

0 references

immunosuppression

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

A Verma

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

S Williams

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

S Trifilio

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

T Zembower

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

J Mehta

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

0 references

publication date

1 May 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1065-1066

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

The clinical spectrum of pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704485

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704485

21 January 2018

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704485

21 January 2018

Comparison of caspofungin and amphotericin B for invasive candidiasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704485

21 January 2018

Do variations in molecular structure affect the clinical efficacy and safety of lipid-based amphotericin B preparations?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704485

21 January 2018

In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704485

21 January 2018

Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704485

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary extraction and accumulation of lipid formulations of amphotericin B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704485

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1704485

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44817223&oldid=2206940423"